Table of Contents

company-logo

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

NexImmune Dividend Announcement

• NexImmune does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on NexImmune dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

NexImmune Dividend History

NexImmune Dividend Yield

NexImmune current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing NexImmune stock? Use our calculator to estimate your expected dividend yield:

NexImmune Financial Ratios

P/E ratio-0.02
PEG ratio-0.00
P/B ratio0.34
ROE-526.91%
Payout ratio0.00%
Current ratio0.66
Quick ratio0.66
Cash Ratio0.51

NexImmune Dividend FAQ

Does NexImmune stock pay dividends?
NexImmune does not currently pay dividends to its shareholders.
Has NexImmune ever paid a dividend?
No, NexImmune has no a history of paying dividends to its shareholders. NexImmune is not known for its dividend payments.
Why doesn't NexImmune pay dividends?
There are several potential reasons why NexImmune would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will NexImmune ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While NexImmune has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is NexImmune a dividend aristocrat?
NexImmune is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is NexImmune a dividend king?
NexImmune is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is NexImmune a dividend stock?
No, NexImmune is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy NexImmune stocks?
To buy NexImmune you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy NexImmune stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.